Momenta Pharmaceuticals, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 35,465 63,921 283,068 116,772
Cost of Revenue - - - -
Gross Profit 35,465 63,921 283,068 116,772
Operating Expenses
Research and Development 103,999 80,345 64,657 51,712
Sales, General and Admin. 41,057 43,682 38,710 28,595
Non-Recurring Items - - - -
Other - - - -
Operating Income (109,591) (60,106) 179,701 36,465
Income From Continuing Operations
Add'l Income/Expense Items 1,183 1,458 746 1,154
Earnings Before Interest and Tax (108,408) (58,648) 180,447 37,619
Interest Expense - - 91 329
Earnings Before Tax (108,408) (58,648) 180,356 37,290
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (108,408) (58,648) 180,356 37,290
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (108,408) (58,648) 180,356 37,290
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (108,408) (58,648) 180,356 37,290